−5.02USD
−12.03 MUSD
574.25 KUSD
2.57 M
About Aethlon Medical, Inc.
Sector
Industry
CEO
James B. Frakes
Website
Headquarters
San Diego
Employees (FY)
15
Founded
1991
ISIN
US00808Y4061
FIGI
BBG000L78XT8
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in 1991 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AEMD is 1.42 USD — it has decreased by 1.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aethlon Medical, Inc. stocks are traded under the ticker AEMD.
Aethlon Medical, Inc. is going to release the next earnings report on Jun 26, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Aethlon Medical, Inc. has a max estimate of 23.00 USD and a min estimate of 23.00 USD.
AEMD earnings for the last quarter are −1.22 USD whereas the estimation was −1.40 USD which accounts for 12.86% surprise. Estimated earnings for the next quarter are −1.35 USD. See more details about Aethlon Medical, Inc. earnings.
Aethlon Medical, Inc. revenue for the last quarter amounts to 574.00 K USD despite the estimated figure of 69.55 K USD. In the next quarter revenue is expected to reach 4.76 M USD.
Yes, you can track Aethlon Medical, Inc. financials in yearly and quarterly reports right on TradingView.
AEMD stock has fallen by 15.94% compared to the previous week, the month change is a 16.47% fall, over the last year Aethlon Medical, Inc. has showed a 63.12% decrease.
Like other stocks, AEMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aethlon Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 15.00 employees. See our rating of the largest employees — is Aethlon Medical, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aethlon Medical, Inc. EBITDA is −12.27 M USD, and current EBITDA margin is −2.03 K%. See more stats in Aethlon Medical, Inc. financial statements.